Influence of government price regulation and deregulation on the price of antineoplastic medications in China: a controlled interrupted time series study.

Compared with unregulated antineoplastics, the prices of regulated antineoplastic medications decreased after setting price caps and did not increase after deregulation. To control the rapid growth of oncology medication expenditures, more effective measures than price regulation through price caps for traditional chemotherapy are needed.